Breaking News Instant updates and real-time market news.

MYL

Mylan

$19.67

0.225 (1.16%)

16:30
05/21/19
05/21
16:30
05/21/19
16:30

FDA: Mylan broadens recall of Valsartan tablets

Mylan N.V.External Link Disclaimer announced that its U.S. based Mylan Pharmaceuticals business is expanding its consumer-level voluntary nationwide recall to include all lots of Valsartan-containing products within expiry. The 104 additional lots include 26 lots of Amlodipine and Valsartan Tablets. Reference Link

  • 31

    May

MYL Mylan
$19.67

0.225 (1.16%)

05/08/19
RBCM
05/08/19
NO CHANGE
Target $26
RBCM
Outperform
Mylan price target lowered to $26 from $45 at RBC Capital
RBC Capital analyst Randall Stanicky lowered his price target on Mylan to $26, saying yesterday's 24% stock price plunge and investor frustration are "justified", even though the magnitude of the sell-off may be "overly punitive." The analyst cites the management's forecasting challenges, "delays in responding to industry change", and governance issues as factors in the stock price decline. Stanicky also keeps his Outperform rating and expects the pressure on the company's board to facilitate change to increase.
05/08/19
05/08/19
DOWNGRADE

Fly Intel: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Mylan (MYL) downgraded to Market Perform from Outperform at Wells Fargo with analyst David Maris saying Mylan reported "disappointing" results which missed consensus on several key metrics including revenue and revenue by segment. 2. Inogen (INGN) downgraded to Neutral from Overweight at JPMorgan with analyst Robert Marcus saying the company's in-line Q1 results were overshadowed by a $25M reduction to guidance. 3. Fortive (FTV) downgraded to Equal Weight from Overweight at Morgan Stanley with analyst Joshua Pokrzywinski citing the stock's valuation after a 29% year-to-date advance as well as the sector valuation of "high quality industrials". 4. Farmer Bros. (FARM) downgraded to Neutral from Buy at Roth Capital with analyst Gerry Sweeney saying the company's results were hurt by significant operating issues and Mike Keown stepped down as CEO. 5. 2U (TWOU) downgraded to Neutral from Outperform at Credit Suisse with analyst Brad Zelnick noting the company reported Q1 and lowered its fiscal year revenue guidance, primarily accounting for schools tightening their admissions. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
05/13/19
WELS
05/13/19
NO CHANGE
WELS
Lawsuit against Teva, others to hit generic drug stocks, says Wells Fargo
Wells Fargo analyst David Maris believes the lawsuit by 44 states against 20 generic drugmakers will weigh on generic drug stocks this week and remain an "overhang issue for some time." Actual penalties and damages are impossible to calculate, but could be material, Maris tells investors in a research note. The analyst spoke to the Connecticut attorney general's office this morning and learned they are preparing for trial in these cases. Language the attorney general has used, such as "unprecedented" and his desire to clawback all gains from collusion, should be indicative of the states' intent, Maris writes. He believes that for a sector that is generally highly levered, and with some companies named already facing an overhang from opioid litigation like Teva (TEVA), this is "especially unwelcome news."
05/15/19
WELS
05/15/19
NO CHANGE
WELS
Lawsuit creates overhang for Teva, Mylan, says Wells Fargo
Wells Fargo analyst David Maris continues to be cautious on Teva (TEVA) and Mylan (MYL) following the price fixing lawsuit against generic companies, and said that the lack of criminal charges "does not take away the financial overhang of the suit." The analyst added that this suit may stop "opportunistic price increases in generics." He remains on the sidelines on both Teva and Mylan, both of which he has Market Perform ratings on.

TODAY'S FREE FLY STORIES

VBIV

VBI Vaccines

$0.64

-1.2486 (-66.06%)

, DVAX

Dynavax

$4.09

0.28 (7.35%)

07:07
06/18/19
06/18
07:07
06/18/19
07:07
Recommendations
VBI Vaccines, Dynavax analyst commentary  »

VBI Vaccines price target…

VBIV

VBI Vaccines

$0.64

-1.2486 (-66.06%)

DVAX

Dynavax

$4.09

0.28 (7.35%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AKG

Asanko Gold

07:06
06/18/19
06/18
07:06
06/18/19
07:06
Initiation
Asanko Gold initiated  »

Asanko Gold initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NTRP

Neurotrope

$6.40

0.235 (3.81%)

07:06
06/18/19
06/18
07:06
06/18/19
07:06
Initiation
Neurotrope initiated  »

Neurotrope initiated with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Jun

UBX

Unity Biotechnology

$9.19

0.5 (5.75%)

07:06
06/18/19
06/18
07:06
06/18/19
07:06
Hot Stocks
Unity Biotechnology says UBX0101 was safe, well-tolerated in Phase 1 study »

UNITY Biotechnology…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Jun

RCKT

Rocket Pharmaceuticals

$16.88

0.68 (4.20%)

07:06
06/18/19
06/18
07:06
06/18/19
07:06
Hot Stocks
Rocket Pharmaceuticals commences dosing in Phase 1 RP-A501 trial »

Rocket Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BBY

Best Buy

$66.66

0.64 (0.97%)

07:05
06/18/19
06/18
07:05
06/18/19
07:05
Hot Stocks
Best Buy to sell Flywheel bikes, Hydrow machines in over 100 stores by EOY »

Best Buy announced a new…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

XEBEF

Xebec Adsorption

$0.00

(0.00%)

07:04
06/18/19
06/18
07:04
06/18/19
07:04
Initiation
Xebec Adsorption initiated  »

Xebec Adsorption…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

VYGR

Voyager Therapeutics

$26.78

2.53 (10.43%)

07:04
06/18/19
06/18
07:04
06/18/19
07:04
Recommendations
Voyager Therapeutics analyst commentary  »

Voyager Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MOS

Mosaic

$23.27

0.91 (4.07%)

07:04
06/18/19
06/18
07:04
06/18/19
07:04
Hot Stocks
Mosaic to close idled Plant City manufacturing facility in Florida »

Mosaic announced that it…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Nov

TWLO

Twilio

$140.75

0.58 (0.41%)

07:04
06/18/19
06/18
07:04
06/18/19
07:04
Initiation
Twilio initiated  »

Twilio initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jun

  • 19

    Jun

ACM

Aecom

$35.20

1.795 (5.37%)

07:02
06/18/19
06/18
07:02
06/18/19
07:02
Recommendations
Aecom analyst commentary  »

Aecom price target raised…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AAPL

Apple

$193.90

1.06 (0.55%)

07:01
06/18/19
06/18
07:01
06/18/19
07:01
Recommendations
Apple analyst commentary  »

KeyBanc lowers FY20 Apple…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SFL

Ship Finance

$12.23

0.11 (0.91%)

07:00
06/18/19
06/18
07:00
06/18/19
07:00
Conference/Events
Ship Finance management to meet with BTIG »

Group Luncheon with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Jun

GHDX

Genomic Health

$52.13

0.99 (1.94%)

07:00
06/18/19
06/18
07:00
06/18/19
07:00
Recommendations
Genomic Health analyst commentary  »

Deutsche Bank places…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jun

  • 06

    Aug

07:00
06/18/19
06/18
07:00
06/18/19
07:00
General news
FX Update: The dollar traded firmer »

FX Update: The dollar…

KR

Kroger

$24.36

0.1 (0.41%)

06:59
06/18/19
06/18
06:59
06/18/19
06:59
Recommendations
Kroger analyst commentary  »

Kroger price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Jun

  • 27

    Jun

ADM

Archer Daniels

$40.73

-0.06 (-0.15%)

06:59
06/18/19
06/18
06:59
06/18/19
06:59
Periodicals
Archer Daniels to cut roughly 130 staff at Neovia business, Reuters reports »

Archer Daniels plans to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Nov

LCI

Lannett

$5.29

0.03 (0.57%)

06:57
06/18/19
06/18
06:57
06/18/19
06:57
Hot Stocks
Lannett commences marketing for Aspirin, Dipyridamole Capsules »

Lannett announced that it…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CNHI

CNH Industrial

$9.45

-0.03 (-0.32%)

06:56
06/18/19
06/18
06:56
06/18/19
06:56
Upgrade
CNH Industrial rating change  »

CNH Industrial upgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

UBER

Uber

$43.75

0.53 (1.23%)

06:54
06/18/19
06/18
06:54
06/18/19
06:54
Periodicals
Uber, Careem to remain separate entities until at least Q1 of 2020, Reuters says »

Uber and Careem, a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AMN

AMN Healthcare

$52.17

0.62 (1.20%)

06:53
06/18/19
06/18
06:53
06/18/19
06:53
Recommendations
AMN Healthcare analyst commentary  »

AMN Healthcare price…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RVNC

Revance

$11.30

0.45 (4.15%)

06:53
06/18/19
06/18
06:53
06/18/19
06:53
Conference/Events
Revance management to meet with Needham »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Jun

  • 20

    Jun

  • 10

    Jul

  • 11

    Jul

TER

Teradyne

$44.08

0.07 (0.16%)

, COHU

Cohu

$15.77

0.07 (0.45%)

06:53
06/18/19
06/18
06:53
06/18/19
06:53
Recommendations
Teradyne, Cohu, FormFactor analyst commentary  »

Semiconductor test…

TER

Teradyne

$44.08

0.07 (0.16%)

COHU

Cohu

$15.77

0.07 (0.45%)

FORM

FormFactor

$14.38

-0.11 (-0.76%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Jul

  • 10

    Jul

EXK

Endeavour Silver

$1.87

0.03 (1.63%)

06:52
06/18/19
06/18
06:52
06/18/19
06:52
Hot Stocks
Endeavour Silver receives final tailings permit for Terronera project »

Endeavour Silver…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

REED

Reed's

$3.71

0.01 (0.27%)

06:50
06/18/19
06/18
06:50
06/18/19
06:50
Conference/Events
Reed's management to meet with Lake Street »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jun

  • 19

    Jun

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.